Target intelligence / Profile preview

MRM3 antisense RNA 1 (MRM3-AS1)

Target
MRM3-AS1
Molecular classification
Other (non-coding RNA), Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

MRM3 antisense RNA 1 (MRM3-AS1) is classified as a long non-coding RNA (lncRNA) gene located on human chromosome 3[1]. It is transcribed antisense to the MRM3 gene and does not encode a protein product[1]. The biological function of MRM3-AS1 has not been experimentally characterized or linked to specific molecular or clinical phenotypes in currently available biomedical literature or reference databases[1]. Antisense RNAs like MRM3-AS1 can, in general, regulate the expression of neighboring or overlapping genes at various levels (transcription, RNA splicing, stability, translation) and may influence chromatin state or interact with protein complexes important for gene expression[4]. However, there are no data supporting a direct disease role, therapeutic relevance, or interaction with drugs for MRM3-AS1. This makes it distinct from antisense lncRNAs such as MCM3AP-AS1, which have reported roles in cancer biology[2]. Key Notes: - MRM3-AS1 should not be confused with MCM3AP-AS1, which is a well-studied lncRNA implicated in cancer[2]. - There is currently insufficient evidence that MRM3-AS1 is a therapeutic target, a biomarker, or a disease-associated molecule. This entry is primarily a locus/gene annotation and does not describe a conventional therapeutic target such as a receptor, enzyme, transporter, or disease-associated protein. Thus, it is classified as is_target: false and is_incorrect: true for the purposes of standard therapeutic target annotations.

02

Mechanism of action

No drugs identified; as an lncRNA, possible mechanisms generally include regulation of mRNA or chromatin states

03

Biological functions

Regulation of gene expression (typically in cis or trans to protein-coding genes)May participate in chromatin modification or regulation of mRNA stability or translationNo direct, characterized molecular function specific to MRM3-AS1 has been described in the literature reviewed

Beyond the preview

Go deeper on MRM3 antisense RNA 1 (MRM3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MRM3 antisense RNA 1 (MRM3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call